Company Filing History:
Years Active: 2022-2023
Title: Burak Dura: Innovator in Nucleic Acid Editing Technologies
Introduction
Burak Dura is a prominent inventor based in Boulder, Colorado, known for his significant contributions to the field of nucleic acid editing. With a total of four patents to his name, Dura has been at the forefront of developing innovative methods and instruments that enhance the capabilities of genetic engineering in mammalian cells.
Latest Patents
Dura's latest patents include groundbreaking technologies such as "Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery." This invention focuses on the automated editing of mammalian cells, utilizing viral delivery systems to ensure precise genetic modifications. Another notable patent is "Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells using microcarriers." This technology involves creating reagent bundles that facilitate the efficient transfection and editing of live mammalian cells, allowing for enhanced growth and editing capabilities.
Career Highlights
Burak Dura is currently employed at Inscripta, Inc., a company dedicated to advancing genetic engineering technologies. His work at Inscripta has positioned him as a key player in the development of automated systems for nucleic acid editing, contributing to the broader field of biotechnology.
Collaborations
Dura collaborates with notable colleagues such as Phillip Belgrader and Christian Siltanen, who share his passion for innovation in genetic engineering. Their combined expertise fosters a collaborative environment that drives forward-thinking solutions in the industry.
Conclusion
Burak Dura's contributions to nucleic acid editing technologies exemplify the impact of innovative thinking in biotechnology. His patents and work at Inscripta, Inc. highlight the importance of advancing genetic engineering methods for future applications.